Therapy for foetal pericardial tumours: survival following in utero shunting, and literature review.
We report the first case of foetal pericardial teratoma, treated successfully in utero by pericardio-amniotic shunting, and review the relevant literature. Foetal treatment improves survival in case of hydrops. Foetal pericardio-amniotic shunting could possibly be an alternative to serial pericardiocentesis.
Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium. roland.devlieger@uz.kuleuven.ac.be
R
R
Devlieger
A
A
Hindryckx
T
T
Van Mieghem
A
A
Debeer
L
L
De Catte
M
M
Gewillig
L
L
Gucciardo
J
J
Deprest
B
B
Meyns
D000328:Adult; D006348:Cardiac Surgical Procedures; D002305:Cardiac Tamponade / Q000196:embryology / Q000628:therapy; D002404:Catheterization; D002585:Cesarean Section; D005260:Female; D006338:Heart Neoplasms / Q000000981:diagnostic imaging / Q000196:embryology / Q000628:therapy*; D006801:Humans; D015160:Hydrops Fetalis / Q000209:etiology / Q000628:therapy; D007231:Infant, Newborn; D010490:Pericardial Effusion / Q000196:embryology / Q000628:therapy; D020519:Pericardiocentesis; D010496:Pericardium / Q000196:embryology / Q000601:surgery; D011247:Pregnancy; D056346:Sternotomy; D013724:Teratoma / Q000000981:diagnostic imaging / Q000196:embryology / Q000628:therapy*; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler; D016216:Ultrasonography, Prenatal